Core C: Biostatistics & Bioinformatics Core
- Institution
- SLOAN-KETTERING INST CAN RESEARCH, NY
- Principal investigator
- Mithat Gonen
- Funding
- $213K
- Duration
- 2001–2027
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY/ABSTRACT The role of the Biostatistics and Bioinformatics Core is to support investigators of the SPORE in Prostate Cancer at Memorial Sloan Kettering Cancer Center in their research efforts, including laboratory experiments, the design and analysis of clinical trials, and bioinformatics analyses. For preclinical studies, core members will assist in the formulation of the experimental design and in the analysis and interpretation of the data at the conclusion of the studies. A core member will conduct a protocol review with SPORE investigators during the clinical trial design phase. Based on this review, we will provide a statistical section for the protocol, outlining major scientific objectives, population to be studied, primary and secondary endpoints, experimental design, a randomization procedure if necessary, analysis plans, and a targeted sample size justified in probabilistic terms. At the conclusion of the trial, data analyses will be performed to assess outcomes of the primary and secondary endpoints stated in the protocol. A similar strategy will be employed for genomic analyses and core members will be integrated to the individual studies early on, remain involved, and carry full responsibility for all quantitative aspects.
LOADING MOONBASE SCORE
Questions for SLOAN-KETTERING INST CAN RESEARCH
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Sloan-Kettering Inst Can ResearchNot yet scored
Core 3: Biostatistics
Mithat Gonen · $235K · 2021–2026
- NIH · Sloan-Kettering Inst Can ResearchNot yet scored
Biostatistics
Mithat Gonen · $614K · 1997–2026
- NIH · Sloan-Kettering Inst Can Research60
Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient
Jesse Joshua Smith · $80K · 2025